Metagenomic Study of the MESA: Detection of Gemella Morbillorum and Association With Coronary Heart Disease
- PMID: 39344648
- PMCID: PMC11681464
- DOI: 10.1161/JAHA.124.035693
Metagenomic Study of the MESA: Detection of Gemella Morbillorum and Association With Coronary Heart Disease
Abstract
Background: Inflammation is a feature of coronary heart disease (CHD), but the role of proinflammatory microbial infection in CHD remains understudied.
Methods and results: CHD was defined in the MESA (Multi-Ethnic Study of Atherosclerosis) as myocardial infarction (251 participants), resuscitated arrest (2 participants), and CHD death (80 participants). We analyzed sequencing reads from 4421 MESA participants in the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine program using the PathSeq workflow of the Genome Analysis Tool Kit and a 65-gigabase microbial reference. Paired reads aligning to 840 microbes were detected in >1% of participants. The association of the presence of microbe reads with incident CHD (follow-up, ~18 years) was examined. First, important variables were ascertained using a single regularized Cox proportional hazard model, examining change of risk as a function of presence of microbe with age, sex, education level, Life's Simple 7, and inflammation. For variables of importance, the hazard ratio (HR) was estimated in separate (unregularized) Cox proportional hazard models including the same covariates (significance threshold Bonferroni corrected P<6×10-5, 0.05/840). Reads from 2 microbes were significantly associated with CHD: Gemella morbillorum (HR, 3.14 [95% CI, 1.92-5.12]; P=4.86×10-6) and Pseudomonas species NFACC19-2 (HR, 3.22 [95% CI, 2.03-5.41]; P=1.58×10-6).
Conclusions: Metagenomics of whole-genome sequence reads opens a possible frontier for detection of pathogens for chronic diseases. The association of G morbillorum and Pseudomonas species reads with CHD raises the possibilities that microbes may drive atherosclerotic inflammation and that treatments for specific pathogens may provide clinical utility for CHD reduction.
Keywords: Gemella morbillorum; MESA; Pseudomonas; cardiovascular heart disease; metagenomics.
Similar articles
-
Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.JAMA Cardiol. 2017 Dec 1;2(12):1332-1340. doi: 10.1001/jamacardio.2017.4191. JAMA Cardiol. 2017. PMID: 29117273 Free PMC article.
-
Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.JAMA Netw Open. 2021 Jan 4;4(1):e2030435. doi: 10.1001/jamanetworkopen.2020.30435. JAMA Netw Open. 2021. PMID: 33399855 Free PMC article.
-
Association Between Self-rated Health, Coronary Artery Calcium Scores, and Atherosclerotic Cardiovascular Disease Risk: The Multi-Ethnic Study of Atherosclerosis (MESA).JAMA Netw Open. 2019 Feb 1;2(2):e188023. doi: 10.1001/jamanetworkopen.2018.8023. JAMA Netw Open. 2019. PMID: 30768193 Free PMC article.
-
Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis.Atherosclerosis. 2011 Dec;219(2):616-22. doi: 10.1016/j.atherosclerosis.2011.08.038. Epub 2011 Aug 31. Atherosclerosis. 2011. PMID: 21930271
-
Brain abscess caused by Gemella morbillorum: case report and review of the literature.Turk Neurosurg. 2012;22(3):374-7. doi: 10.5137/1019-5149.JTN.3634-10.0. Turk Neurosurg. 2012. PMID: 22665012 Review.
Cited by
-
Persea americana Peel: A Promising Source of Nutraceutical for the Mitigation of Cardiovascular Risk in Arthritic Rats Through the Gut-Joint Axis.Biomolecules. 2025 Apr 16;15(4):590. doi: 10.3390/biom15040590. Biomolecules. 2025. PMID: 40305360 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- U54 HG003067/HG/NHGRI NIH HHS/United States
- R01 HL071259/HL/NHLBI NIH HHS/United States
- OT3 HL142481/HL/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- OT3 HL142479/HL/NHLBI NIH HHS/United States
- 75N92020D00006/HL/NHLBI NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- OT3 HL142478/HL/NHLBI NIH HHS/United States
- UL1 RR033176/RR/NCRR NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- OT3 HL147154/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 HL146860/HL/NHLBI NIH HHS/United States
- OT3 HL142480/HL/NHLBI NIH HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- HHSN268201500014C/HL/NHLBI NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States